What causes cancer?
Genetic instability which leads to mutations within the cells
Where can mutations come from?
- additional mutations can occur
How does gene expression occur?
This process is highly regulated and controlled
What can population genetics be used for?
It can be used to identify mutation carriers among parents and offspring
What is the two-hit model?
For cancer to form, it has to under go at least two mutations
Why is more than one mutations necessary to cause cancer?
What is the mutation frequency like across cancers?
- each of the shown cancers had more than one mutation in their bases (C to T, C to A, etc.)
What are germline (hereditary) mutations?
What are Familial mutations?
What are sporadic (somatic) mutations?
What is “Sporadic” Cancer?
How does hereditary retinoblastoma form?
Germline mutation
How does nonhereditary retinoblastoma occur?
Somatic mutation
Explain how cancer occur from inherited and sporadic mutations.
Every cell including every ovary cell has the inherited mutation. Sporadic gene mutations occur. Overtime, key gene mutations may add to the inherited mutation and lead to tumor growth and cancer (accumulation of mutations).
What percentage of breast and ovarian cancer is hereditary?
Breast: 5-10%
Ovarian: 5-10%
Both are mostly caused by sporadic mutations
Are mutations within cancers similar?
No, the mutational landscape is spatially different and there is, at most, less than 10% of similarities between mutations
What is significant about the common hereditary genes in cancer?
Why is BRCA significant in the topic of cancer?
BRCA mutations increase the risk of breast and ovarian cancer
- it increases the risk as the patient ages
What is BRCA?
If there has been history of breast or ovarian cancer in your patient and they’re high risk, what would you initially suggest they do?
You would refer them to a specialized Hereditary Breast and Ovarian Cancer (HBOC) clinic. They would undergo Germline BRCA testing which results in informed decision-making to decide of form of prevention treatment.
In a BRCA1/2 mutation carrier, what happens if a normal cell, with a functioning BRCA1/2, undergoes a single strand break and is then treated with PARP inhibitor.
The single strand break becomes a double strand break, because BRCA is active, it is able to repair the break and the cell survives.
In a BRCA1/2 mutation carrier, what happens if a tumour cell, with a functioning BRCA1/2, undergoes a single strand break and is then treated with PARP inhibitor.
Once the cell undergoes a double strand break, the BRCA repairs the break resulting in a resistant tumour cell
In a BRCA1/2 mutation carrier, what happens if a tumour cell, with a non-functioning BRCA1/2 due to LOH, undergoes a single strand break and is then treated with PARP inhibitor.
Once the double strand break occurs, the cell becomes synthetically lethal due to the non-functioning BRCA. This results in a sensitive tumour cell.
How have labs discovered targets?
By large-scale genomic screens for synthetic lethality.